Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NRIX |
---|---|---|
09:32 ET | 2963 | 16.34 |
09:34 ET | 100 | 16.46 |
09:36 ET | 200 | 16.59 |
09:38 ET | 500 | 16.535 |
09:39 ET | 3989 | 16.8 |
09:41 ET | 600 | 16.855 |
09:43 ET | 2300 | 16.84 |
09:45 ET | 4480 | 16.88 |
09:48 ET | 900 | 16.76 |
09:50 ET | 4331 | 16.645 |
09:52 ET | 3225 | 16.635 |
09:54 ET | 353 | 16.69 |
09:56 ET | 2268 | 16.75 |
09:57 ET | 1552 | 16.55 |
09:59 ET | 500 | 16.56 |
10:01 ET | 1800 | 16.63 |
10:03 ET | 1497 | 16.7 |
10:06 ET | 1500 | 16.75 |
10:08 ET | 2100 | 16.8 |
10:10 ET | 61105 | 16.88 |
10:12 ET | 1335 | 16.89 |
10:14 ET | 4740 | 16.91 |
10:15 ET | 9586 | 17 |
10:17 ET | 800 | 17.03 |
10:19 ET | 159462 | 16.995 |
10:21 ET | 3389 | 17.03 |
10:24 ET | 6104 | 17.1892 |
10:26 ET | 10622 | 17.15 |
10:28 ET | 4289 | 17.25 |
10:30 ET | 1845 | 17.25 |
10:32 ET | 6951 | 17.165 |
10:33 ET | 11259 | 16.92 |
10:35 ET | 1436 | 16.83 |
10:37 ET | 3346 | 16.88 |
10:39 ET | 2715 | 16.96 |
10:44 ET | 2302 | 16.8 |
10:46 ET | 5149 | 16.91 |
10:48 ET | 1768 | 16.845 |
10:50 ET | 2414 | 16.845 |
10:51 ET | 2727 | 16.87 |
10:53 ET | 1200 | 16.79 |
10:55 ET | 4497 | 16.8211 |
10:57 ET | 2799 | 16.83 |
11:00 ET | 2114 | 16.7301 |
11:02 ET | 2192 | 16.83 |
11:04 ET | 2527 | 16.795 |
11:06 ET | 1264 | 16.78 |
11:08 ET | 1336 | 16.856 |
11:09 ET | 3603 | 16.89 |
11:11 ET | 1500 | 16.77 |
11:13 ET | 1940 | 16.8 |
11:15 ET | 3330 | 16.88 |
11:18 ET | 2300 | 16.81 |
11:20 ET | 1300 | 16.95 |
11:22 ET | 3078 | 17.005 |
11:24 ET | 2527 | 16.9726 |
11:26 ET | 1896 | 17.0744 |
11:27 ET | 1792 | 17.13 |
11:29 ET | 800 | 17.06 |
11:31 ET | 1525 | 17.14 |
11:33 ET | 3141 | 17.221 |
11:36 ET | 4596 | 17.15 |
11:38 ET | 3213 | 16.98 |
11:40 ET | 2271 | 16.91 |
11:42 ET | 2599 | 16.9001 |
11:44 ET | 5223 | 16.95 |
11:45 ET | 4945 | 16.92 |
11:47 ET | 2473 | 16.805 |
11:49 ET | 2711 | 16.71 |
11:51 ET | 1657 | 16.82 |
11:54 ET | 1642 | 16.8 |
11:56 ET | 2454 | 16.79 |
11:58 ET | 1260 | 16.805 |
12:00 ET | 2024 | 16.71 |
12:02 ET | 4393 | 16.62 |
12:03 ET | 1947 | 16.71 |
12:05 ET | 1100 | 16.65 |
12:07 ET | 4544 | 16.65 |
12:09 ET | 3336 | 16.68 |
12:12 ET | 1600 | 16.66 |
12:14 ET | 3000 | 16.665 |
12:16 ET | 4552 | 16.63 |
12:18 ET | 2600 | 16.63 |
12:20 ET | 5522 | 16.6 |
12:21 ET | 2238 | 16.6 |
12:23 ET | 507 | 16.57 |
12:25 ET | 2518 | 16.595 |
12:27 ET | 4730 | 16.58 |
12:30 ET | 3299 | 16.53 |
12:32 ET | 2457 | 16.56 |
12:34 ET | 5911 | 16.6 |
12:38 ET | 1999 | 16.56 |
12:39 ET | 3528 | 16.64 |
12:41 ET | 1000 | 16.64 |
12:43 ET | 5600 | 16.685 |
12:45 ET | 1655 | 16.76 |
12:48 ET | 1227 | 16.83 |
12:50 ET | 3539 | 16.83 |
12:52 ET | 1868 | 16.86 |
12:54 ET | 1527 | 16.84 |
12:56 ET | 3571 | 16.82 |
12:57 ET | 2561 | 16.85 |
12:59 ET | 700 | 16.82 |
01:01 ET | 4374 | 16.85 |
01:03 ET | 3405 | 16.81 |
01:06 ET | 1200 | 16.82 |
01:08 ET | 1939 | 16.82 |
01:10 ET | 2183 | 16.76 |
01:12 ET | 856 | 16.82 |
01:14 ET | 1643 | 16.79 |
01:15 ET | 2725 | 16.81 |
01:17 ET | 500 | 16.8 |
01:19 ET | 1800 | 16.8 |
01:21 ET | 4398 | 16.76 |
01:24 ET | 1140 | 16.71 |
01:26 ET | 1192 | 16.78 |
01:28 ET | 2818 | 16.84 |
01:30 ET | 1672 | 16.815 |
01:32 ET | 2731 | 16.81 |
01:33 ET | 3383 | 16.8 |
01:35 ET | 2050 | 16.86 |
01:37 ET | 3055 | 16.76 |
01:39 ET | 2100 | 16.79 |
01:42 ET | 2100 | 16.805 |
01:44 ET | 2903 | 16.79 |
01:46 ET | 4729 | 16.8 |
01:48 ET | 1106 | 16.84 |
01:50 ET | 2400 | 16.815 |
01:51 ET | 3843 | 16.815 |
01:53 ET | 1227 | 16.835 |
01:55 ET | 7414 | 16.81 |
01:57 ET | 4006 | 16.79 |
02:00 ET | 1912 | 16.785 |
02:02 ET | 8859 | 16.85 |
02:04 ET | 3805 | 16.86 |
02:06 ET | 4335 | 16.815 |
02:08 ET | 8248 | 16.87 |
02:09 ET | 2661 | 16.84 |
02:13 ET | 2170 | 16.825 |
02:15 ET | 4765 | 16.8 |
02:18 ET | 3013 | 16.77 |
02:20 ET | 6141 | 16.79 |
02:22 ET | 2915 | 16.76 |
02:24 ET | 3913 | 16.8 |
02:26 ET | 1100 | 16.79 |
02:27 ET | 2100 | 16.78 |
02:29 ET | 2796 | 16.76 |
02:31 ET | 3556 | 16.77 |
02:33 ET | 300 | 16.755 |
02:36 ET | 5790 | 16.79 |
02:38 ET | 6764 | 16.79 |
02:40 ET | 4150 | 16.69 |
02:42 ET | 848 | 16.705 |
02:44 ET | 4332 | 16.69 |
02:45 ET | 5196 | 16.63 |
02:47 ET | 4415 | 16.635 |
02:49 ET | 8827 | 16.585 |
02:51 ET | 1670 | 16.56 |
02:54 ET | 5380 | 16.55 |
02:56 ET | 9292 | 16.52 |
02:58 ET | 5565 | 16.59 |
03:00 ET | 460 | 16.565 |
03:02 ET | 6910 | 16.57 |
03:03 ET | 4820 | 16.56 |
03:05 ET | 6730 | 16.58 |
03:07 ET | 400 | 16.6 |
03:09 ET | 4968 | 16.58 |
03:12 ET | 5844 | 16.52 |
03:14 ET | 7559 | 16.58 |
03:16 ET | 6263 | 16.6 |
03:18 ET | 100 | 16.61 |
03:20 ET | 5108 | 16.675 |
03:21 ET | 4882 | 16.66 |
03:23 ET | 4216 | 16.62 |
03:25 ET | 2379 | 16.615 |
03:27 ET | 5482 | 16.59 |
03:30 ET | 3934 | 16.58 |
03:32 ET | 6600 | 16.56 |
03:34 ET | 1410 | 16.54 |
03:36 ET | 3691 | 16.61 |
03:38 ET | 8967 | 16.58 |
03:39 ET | 6109 | 16.62 |
03:41 ET | 10503 | 16.72 |
03:43 ET | 300 | 16.75 |
03:45 ET | 3846 | 16.74 |
03:48 ET | 6429 | 16.74 |
03:50 ET | 4684 | 16.77 |
03:52 ET | 3627 | 16.81 |
03:54 ET | 9240 | 16.78 |
03:56 ET | 6600 | 16.775 |
03:57 ET | 7831 | 16.78 |
03:59 ET | 10703 | 16.73 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Nurix Therapeutics Inc | 957.8M | -6.3x | --- |
CureVac NV | 953.3M | -3.0x | --- |
Arcutis Biotherapeutics Inc | 900.6M | -3.2x | --- |
Prothena Corporation PLC | 1.1B | -6.6x | --- |
Gyre Therapeutics Inc | 922.7M | -5.9x | --- |
Zymeworks Inc | 679.5M | -5.1x | --- |
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of small molecules and antibody therapies based on the modulation of cellular protein levels as a treatment approach for cancer, inflammatory conditions and other diseases. It DELigase is an integrated discovery platform, to identify and advance drug candidates targeting E3 ligases. Its drug candidates include NX-2127, NX-5948 and NX-1607. NX-2127 is an orally bioavailable Brutons tyrosine kinase (BTK) degrader that also degrades cereblon neosubstrates IKZF1 (Ikaros) and IKZF3 (Aiolos) for the treatment of relapsed or refractory B-cell malignancies. NX-5948 is an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and potentially autoimmune diseases. NX-1607 is an oral clinical-stage small molecule drug candidate that inhibits Casitas B-lineage lymphoma proto-oncogene-B (CBL-B).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $978.5M |
---|---|
Revenue (TTM) | $80.9M |
Shares Outstanding | 59.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.17 |
EPS | $-2.65 |
Book Value | $4.12 |
P/E Ratio | -6.3x |
Price/Sales (TTM) | 12.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -194.51% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.